SC 13G
PASSAGE BIO, INC.
- Company
- Passage BIO, Inc.
- Filed
- November 14, 2024
- Accession Number
- 0000902664-24-006563
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →